

Advocacy is a core pillar of ERS. The Society’s involvement in advocacy is co-ordinated via the ERS Advocacy Council.
None
None
None
None
Company | Nature of Support | Amount of funds received* |
---|---|---|
DFG | Research grant | D |
Umwelt- und Nachbarschaftshaus | Research grant | D |
Umweltbundesamt | Research grant | D |
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
A | B | C | D |
---|---|---|---|
less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
None
Company | Purpose of Payment | Amount of funds received* |
---|---|---|
Aimmune | Lecture fee | B |
Nestle | Lecture fee | B |
Sanofi | Lecture fee, advisory committee | C |
None
None
Company | Nature of Support | Amount of funds received* |
---|---|---|
Infectopharm | Clinical trial fees | B |
ALK Albello | Clinical Trial fees | B |
Nestle | Unrestricted grant, investigator initiated research | D |
Sanofi | Clinical trial fees | C |
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
A | B | C | D |
---|---|---|---|
less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
None
None
None
None
Company | Nature of Support | Amount of funds received* |
---|---|---|
Fitbit | Unrestricted grant | D |
Novo Nordisk | Unrestricted grant | D |
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
A | B | C | D |
---|---|---|---|
less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
None
Company | Purpose of Payment | Amount of funds received* |
---|---|---|
MSD | lectures | B |
Pfizer | lectures; advisory committee | B |
AstraZeneca | lectures; advisory committee | B |
Takeda | lectures; | B |
Amgen | lectures; | B |
Adamed | lectures; | B |
Grifols | lectures; | B |
CSL Behring | lectures;advisory committee | B |
Mereo Biopharma | advisory committee | B |
Company | Purpose and Nature of Benefit | Amount of funds received* |
---|---|---|
MSD | conference | B |
Amgen | conference | B |
None
Company | Nature of Support | Amount of funds received* |
---|---|---|
Biocartis | donated to my Institution | A |
Pfizer | donated to my Institution | B |
AstraZeneca | reserach grant donated to my Institution | D |
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
A | B | C | D |
---|---|---|---|
less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
Dimitris is a cystic fibrosis patient and advocate as well as Vice President of the Greek Patient Association, and founder of Patients Hub.
He won the European Lung Foundation (ELF) Award in 2021 for his efforts to ensure equal access to innovative treatments and health services for all.
None
Company | Purpose of Payment | Amount of funds received* |
---|---|---|
AZ | Member of advisory board | B |
Chiesi | Speaker | A |
Chiesi | Chapter writer | A |
None
None
Company | Nature of Support | Amount of funds received* |
---|---|---|
AZ | Research project on COVID | C |
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
A | B | C | D |
---|---|---|---|
less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |
None
Company | Purpose of Payment | Amount of funds received* |
---|---|---|
ResMed | Sponsorship to attend and present at symposium at World Sleep Congress 2022 | B |
European Medicines Agency | Emergency Task Force member - attendance at committee meetings | B |
ACI Clinical | Member of Endpoint Committee for bioALS Trial | B |
None
None
None
None
No. I declare that I have not been full or part time employee of, paid consultant or advisor to /received a grant from the tobacco industry at any time after 1.1.2000, for any project or programme.
A | B | C | D |
---|---|---|---|
less than € 1'000 | € 1001 - € 5'000 | € 5'001 - € 20'000 | more than € 20'000 |